US President Donald Trump recently ordered a funding pause
for HIV treatment in developing countries as part of an executive order on
foreign aid.
As a result, the US department of state suspended the
disbursement of funds from the president’s emergency plan for AIDS relief
(PEPFAR).
PEPFAR is providing HIV treatment for more than 20 million
people living with the disease in Nigeria and globally, including 566,000
children under 15 years of age.
But the joint United Nations programme on HIV/AIDS in a
statement on Wednesday said the US government approved a waiver that allows
people living with HIV to continue accessing treatment.
“UNAIDS welcomes this waiver from the US government which
ensures that millions of people living with HIV can continue to receive
life-saving HIV medication during the assessment of US foreign development
assistance,” the statement reads.
“This urgent decision recognises PEPFAR’s critical role in
the AIDS response and restores hope to people living with HIV.”
Reacting to the development, Toyin Aderibigbe, the
spokesperson of the National Agency for the Control of AIDS (NACA), said
Nigeria appreciates the US government’s waiver and is mindful of the potential
change to foreign aid soon under the new administration.
“The Nigerian government would intensify domestic resource
mobilisation strategies towards ownership and sustainability of the HIV
response in the country with a view to reducing the risks of donor aid policy
shifts to the HIV response while ensuring that the country’s strategic goals
and targets in the fight against HIV are achieved,” Aderibigbe said in a
statement issued on Thursday.
“Through effective stakeholder collaboration, creating
favourable policies, and enabling environment and advocacy to policymakers,
Nigeria can still achieve the target of ending AIDS by 2030.”
“The US government, through PEPFAR, has immensely supported
Nigeria’s HIV/AIDS response over the years, particularly in sustaining the
treatment of people living with HIV in Nigeria.
“PEPFAR Nigeria remains the biggest donor for treatment
programmes in the country, as their contributions cover approximately 90
percent of the treatment burden.”